New pill aims to slow aggressive cancers in patients on pain meds
NCT ID NCT07354919
Summary
This study is testing whether a daily pill called axelopran can help slow down cancer growth in people with advanced lung, breast, pancreas, or prostate cancer who are taking opioid pain medication. It will involve about 34 participants who have tried standard treatments and will take the pill for up to a year while doctors monitor their tumors and quality of life. The main goal is to see if the drug shows signs of keeping the cancer from getting worse over six weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HealthPartners Cancer Center at Regions Hospital
Saint Paul, Minnesota, 55101, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HealthPartners Frauenshuh Cancer Research Center
Saint Louis Park, Minnesota, 55426, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.